跳至主要内容
临床试验/ACTRN12608000536369
ACTRN12608000536369已完成2 期

Kava Anxiety Depression Spectrum Study: A Human Clinical Trial to Treat Generalised Anxiety.

niversity of Queensland0 个研究点目标入组 60 人开始时间: 2008年10月22日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • Chronic anxiety >2 weeks (>10 Beck Anxiety Inventory: BAI).

排除标准

  • Use of synthetic antidepressants.
  • Psychotic/ Bipolar illness.
  • Significant suicidal ideation in the previous 6 months.
  • Diagnosed hepato-bilary disease/inflammation.
  • Substance abuse disorder including alcohol in the previous 6 months.
  • Use of benzodiazepines or opiates in the previous month.
  • Previous adverse reaction to kava.
  • Seeing a psychologist or counsellor currently or in the previous month.
  • Lack of facility in written or spoken English.
  • Currently pregnant or lactating

研究者

发起方
niversity of Queensland

相似试验